Variable | Subjects with fibrosis 0–1 (n = 43) | Subjects with fibrosis ≥ 2 (n = 37) | p |
---|---|---|---|
Age (years) (mean ± SD) | 50.2 ± 11.9 | 57.8 ± 12.9 | 0.008 |
Weight (kg) (mean ± SD) | 75.3 ± 14.0 | 83.2 ± 20.4 | 0.045 |
BMI (kg/m2) (mean ± SD) | 27.4 ± 5.1 | 30.3 ± 5.7 | 0.017 |
SBP (mm/Hg) (mean ± SD) | 117.8 ± 11.7 | 126.2 ± 14.6 | 0.006 |
DBP (mm/Hg) (mean ± SD) | 71.9 ± 8.4 | 73.6 ± 10.8 | 0.440 |
Gender M/F | 24/19 | 16/21 | 0.262 |
Hypertension (n/%) | 11 (25.6) | 17 (45.9) | 0.057 |
Diabetes (n/%) | 10 (23.3) | 21 (56.8) | 0.002 |
dyslipidemia (n/ %) | 7 (16.3) | 8 (21.6) | 0.542 |
Previous cardiovascular diseases | 0 (0) | 3 (8.1) | 0.057 |
Previous cerebrovascular events | 0 | 0 | / |
RHI (mean ± SD) | 1.9 ± 0.54 | 1.8 ± 0.47 | 0.211 |
Aix (%) | 139.8 ± 29.4 | 149.7 ± 23.6 | 0.103 |
(mean ± SD) | 25.8 ± 13.2 | 31.9 ± 10.4 | 0.027 |
PWV (mt/s) (mean ± SD) | 10.0 ± 1.9 | 10.9 ± 2.3 | 0.043 |
MMSE (mean ± SD) | 27.8 ± 2.2 | 26.9 ± 2.9 | 0.131 |
Liver stiffness, kPa | 7.5 ± 3.6 | 12.6 ± 8.9 | 0.001 |
Histology (%) | |||
Kleiner steatosis grade 0–3 | |||
1 (n/%) | 29 (67.4) | 7 (18.9) | |
2 (n/%) | 7 (16.3) | 15 (40.5) | < 0.0005 |
3 (n/%) | 7 (16.3) | 15 (40.5) | |
Lobular inflammation grade 0–3 | |||
0 (n/%) | 2 (4.6) | 0 | |
1 (n/%) | 36 (83.7) | 9 (24.3) | |
2 (n/%) | 4 (9.3) | 27 (73.0) | < 0.0005 |
3 (n/%) | 1 (2.3) | 1 (2.7) | |
Hepatocellular ballooning (0–2) | |||
0 (n/%) | 21 (48.8) | 2 (5.4) | |
1 (n/%) | 20 (46.5) | 15 (40.5) | < 0.0005 |
2 (n/%) | 2 (4.6) | 20 (54.0) |